Duloxetine for the treatment of generalized anxiety disorder: a review

QR Code

Duloxetine for the treatment of generalized anxiety disorder: a review

Ahsan Y Khan, Matthew MacalusoDepartment of Psychiatry and Behavioral Sciences, University of Kansas School of Medicine-Wichita, Wichita, KS, USAAbstract: Approximately 16 million people in the United States suffer from anxiety disorders alone, while another 12 million experience both anxiety and at...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Ahsan Y Khan, Matthew Macaluso
Format:	article
Langue:	EN
Publié:	Dove Medical Press 2008
Sujets:	Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Accès en ligne:	https://doaj.org/article/f63f5d7fc50b4c749c15dcfa5823076f
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Duloxetine in the treatment of generalized anxiety disorder
par: Trevor R Norman, et autres
Publié: (2009)

The role of duloxetine in the treatment of anxiety disorders
par: Domenico De Berardis, et autres
Publié: (2008)

Pregabalin for the treatment of generalized anxiety disorder: an update
par: Baldwin DS, et autres
Publié: (2013)

Duloxetine in panic disorder with somatic gastric pain
par: Preve M, et autres
Publié: (2013)

Profile of agomelatine and its potential in the treatment of generalized anxiety disorder
par: Levitan MN, et autres
Publié: (2015)

New treatment options for fibromyalgia: critical appraisal of duloxetine
par: Nurcan &Uuml;&ccedil;eyler, et autres
Publié: (2008)

Differential attentional bias in generalized anxiety disorder and panic disorder
par: Chen J, et autres
Publié: (2013)

New developments in the management of major depressive disorder and generalized anxiety disorder: role of quetiapine
par: Bernhard T Baune
Publié: (2008)

Clinical efficacy and safety of fluoxetine in generalized anxiety disorder in Chinese patients
par: Zou C, et autres
Publié: (2013)

Impact of dissociation on treatment of depressive and anxiety spectrum disorders with and without personality disorders
par: Prasko J, et autres
Publié: (2016)

Escitalopram vs duloxetine in acute treatment of major depressive disorder: meta-analysis and systematic review
par: Maneeton B, et autres
Publié: (2018)

Evidence to practice: treatment of anxiety in individuals with autism spectrum disorders
par: Russell Lang, et autres
Publié: (2011)

Increase in IL-6 levels among major depressive disorder patients after a 6-week treatment with duloxetine 60 mg/day: a preliminary observation
par: Michele Fornaro, et autres
Publié: (2011)

Radioelectric brain stimulation in the treatment of generalized anxiety disorder with comorbid major depression in a psychiatric hospital: a pilot study
par: Fontani V, et autres
Publié: (2011)

Efficacy comparison of duloxetine and SSRIs at doses approved in Japan
par: Harada E, et autres
Publié: (2015)

Cognitive impairment in generalized anxiety disorder revealed by event-related potential N270
par: Yang Y, et autres
Publié: (2015)

A review of neuroimaging studies of anxiety disorders in China
par: Chen J, et autres
Publié: (2011)

Catechol-O-methyltransferase Val158Met genotype and the clinical responses to duloxetine treatment or plasma levels of 3-methoxy-4-hydroxyphenylglycol and homovanillic acid in Japanese patients with major depressive disorder
par: Atake K, et autres
Publié: (2015)

Social anxiety disorder: A review of environmental risk factors
par: Christina A Brook, et autres
Publié: (2008)

Disability in patients consulting for anxiety or mood disorders in primary care: response to antidepressant treatment
par: G&eacute;rard A, et autres
Publié: (2012)

Effects of once-daily extended release quetiapine fumarate on patient-reported outcomes in patients with generalized anxiety disorder
par: Endicott J, et autres
Publié: (2012)

Comparative clinical profile of mirtazapine and duloxetine in practical clinical settings in Japan: a 4-week open-label, parallel-group study of major depressive disorder
par: Nagao K, et autres
Publié: (2013)

Anxiety disorders and GABA neurotransmission: a disturbance of modulation
par: Nuss P
Publié: (2015)

Group cognitive behavioral therapy for patients with generalized social anxiety disorder in Japan: outcomes at 1-year follow up and outcome predictors
par: Kawaguchi A, et autres
Publié: (2013)

Treatment discontinuation and tolerability as a function of dose and titration of duloxetine in the treatment of major depressive disorder
par: Harada E, et autres
Publié: (2016)

Individual correlates of self-stigma in patients with anxiety disorders with and without comorbidities
par: Ociskova M, et autres
Publié: (2015)

Comparison of duloxetine and SSRI as a treatment option of painful physical symptoms associated with major depressive disorder
par: Haider M, et autres
Publié: (2017)

A review of ramelteon in the treatment of sleep disorders
par: David N Neubauer
Publié: (2008)

Levomilnacipran for the treatment of major depressive disorder: a review
par: Asnis GA, et autres
Publié: (2015)

Correlation between pain response and improvements in patient-reported outcomes and health-related quality of life in duloxetine-treated patients with diabetic peripheral neuropathic pain
par: Ogawa K, et autres
Publié: (2015)

Review of risperidone for the treatment of pediatric and adolescent bipolar disorder and schizophrenia
par: Jeffrey R Bishop, et autres
Publié: (2008)

Indiplon in the treatment of sleep disorders
par: Alan Lankford
Publié: (2007)

Aripiprazole for the maintenance treatment of bipolar disorder: a review of available evidence
par: McIntyre R, et autres
Publié: (2011)

Disorder-specific dysfunction in dorsal anterior cingulate cortex and parietal cortex during cognitive reappraisal in anxiety disorder [Letter]
par: Wang HY, et autres
Publié: (2019)

Frequency and risk factor analysis of cognitive and anxiety-depressive disorders in patients with amyotrophic lateral sclerosis/motor neuron disease
par: Cui F, et autres
Publié: (2015)

Ziprasidone in the treatment of mania in bipolar disorder
par: Stephen E Nicolson, et autres
Publié: (2007)

Armodafinil in the treatment of sleep/wake disorders
par: Jonathan RL Schwartz, et autres
Publié: (2010)

Desvenlafaxine in the treatment of major depressive disorder
par: Maria Teresa C Lourenco1, et autres
Publié: (2009)

Atomoxetine for the treatment of attention-deficit/hyperactivity disorder in children and adolescents: a review
par: Paul Hammerness, et autres
Publié: (2009)

Cognitive behavioral therapy for the treatment of post-traumatic stress disorder: a review
par: Kar N
Publié: (2011)